Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Survival”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Testing effectiveness (Phase 2)Study completedNCT01229761
What this trial is testing

Study to Improve Survival Among HIV-Exposed Infants in Botswana

Who this might be right for
HIV InfectionsNeutropeniaAnemia
Harvard School of Public Health (HSPH) 3,724
Not applicableStudy completedNCT04936399
What this trial is testing

Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Who this might be right for
Esophageal Squamous Cell Carcinoma
Bristol-Myers Squibb 87
Large-scale testing (Phase 3)Study completedNCT00775307
What this trial is testing

Adjuvant Pazopanib in Stage I NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 142
Large-scale testing (Phase 3)Looking for participantsNCT04876651
What this trial is testing

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Ltd 392
Not applicableNot Yet RecruitingNCT07313709
What this trial is testing

Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.

Who this might be right for
Brain Cancer
University of Cincinnati 40
Not applicableLooking for participantsNCT06755762
What this trial is testing

Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer

Who this might be right for
Circulating Tumor CellHNSCC
Chang Gung Memorial Hospital 88
Not applicableNot Yet RecruitingNCT07218328
What this trial is testing

Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families

Who this might be right for
Pediatric Cancer
M.D. Anderson Cancer Center 21
Not applicableStudy completedNCT04366765
What this trial is testing

COVID-19 Survival - The COVIVA Study

Who this might be right for
COVID-19SARS-CoV 2
University Hospital, Basel, Switzerland 1,325
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Post-approval studies (Phase 4)Study completedNCT00994825
What this trial is testing

Levosimendan in High Risk Patients Undergoing Cardiac Surgery

Who this might be right for
Low Cardiac Output Syndrome
Università Vita-Salute San Raffaele 1,000
Post-approval studies (Phase 4)Looking for participantsNCT05894694
What this trial is testing

Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Carcinoma
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 320
Early research (Phase 1)UnknownNCT01624077
What this trial is testing

Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance

Who this might be right for
Chronic Rejection of Liver Transplant
Nanjing Medical University 1
Not applicableLooking for participantsNCT06882148
What this trial is testing

Drug Survival of Target Therapies in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,167
Not applicableLooking for participantsNCT06608420
What this trial is testing

Precision Medicine for L/GCMN and Melanoma 1

Who this might be right for
Melanoma (Skin Cancer)Nevi and Melanomas
Fundacion Clinic per a la Recerca Biomédica 6,000
Not applicableStudy completedNCT04647110
What this trial is testing

Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.

Who this might be right for
ALK-positive NSCLC
Pfizer 549
Not applicableStudy completedNCT03417050
What this trial is testing

Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Who this might be right for
Coronary Artery Disease
Erasmus Medical Center 2,636
Not applicableActive Not RecruitingNCT07136051
What this trial is testing

Evaluation of the Survival of Fissure Sealants Applied With Different Pretreatment Methods on Permanent First Molars: A One-Year Follow-Up

Who this might be right for
Fissure SealantDeproteinizationBonding Agent+2 more
Handan Vural 40
Not applicableStudy completedNCT01649817
What this trial is testing

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 183
Not applicableActive Not RecruitingNCT02936505
What this trial is testing

Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.

Who this might be right for
Lung TransplantationAllografts
Vastra Gotaland Region 249
Not applicableStudy completedNCT05789316
What this trial is testing

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Who this might be right for
Head and Neck Cancer SurvivorsCancer of the Head and Neck Surviors
Washington University School of Medicine 55
Load More Results